XDH and hyperuricemia: Currently, urate-lowering drugs include xanthine oxidoreductase (XOR) inhibitors, which inhibit urate production, and uricosuric drugs; however, XOR inhibitors are recommended for patients with renal impairment, regardless of the type of hyperuricemia (1, 6).